1. CD8+ T-Cell Density Imaging with 64Cu-Labeled Cys-Diabody Informs Immunotherapy Protocols
   Jai Woong Seo et al, 2018, Clinical Cancer Research CrossRef
2. Immune cell therapy for hepatocellular carcinoma
   Eishiro Mizukoshi et al, 2019, Journal of Hematology & Oncology CrossRef
3. Effective combination therapy of percutaneous ethanol injection and chemotherapy based on injectable low molecular weight gels
   Guotao Li et al, 2018, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
4. Effect of dendritic cell–based immunotherapy on hepatocellular carcinoma: A systematic review and meta-analysis
   CONG CHEN et al, 2018, Cytotherapy CrossRef
5. Review of clinical tumor ablation advance in Asia
   Luo Wang et al, 2021, International Journal of Hyperthermia CrossRef
6. A general strategy towards an injectable microwave-sensitive immune hydrogel for combined percutaneous microwave ablation and immunotherapy
   Yuting Cao et al, 2021, Chemical Engineering Journal CrossRef
7. Immunological effect of local ablation combined with immunotherapy on solid malignancies
   Yusuke Takahashi et al, 2017, Chinese Journal of Cancer CrossRef
8. Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decades
   Cheng-Long Han et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
9. Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis
   Jing Cao et al, 2019, World Journal of Gastroenterology CrossRef
10. Utility of miR‑133a‑3p as a diagnostic indicator for hepatocellular carcinoma: An investigation combined with GEO, TCGA, meta‑analysis and bioinformatics
    Hai‑Wei Liang et al, 2017, Molecular Medicine Reports CrossRef
11. In-situ tumor vaccination by percutaneous ablative therapy and its synergy with immunotherapeutics: An update on combination therapy
    Nicole J. Kim et al, 2023, Frontiers in Immunology CrossRef
12. Microwave ablation for liver tumors
    Jian-ping Dou et al, 2016, Abdominal Radiology CrossRef
13. Thermal ablation and immunotherapy for hepatocellular carcinoma: Recent advances and future directions
    Xiao-Wan Bo et al, 2021, World Journal of Gastrointestinal Oncology CrossRef
14. Camrelizumab combined with microwave ablation improves the objective response rate in advanced non-small cell lung cancer
    Xin Ye et al, 2019, Journal of Cancer Research and Therapeutics CrossRef
15. Peripheral Blood Biomarkers Associated With Outcome in Non-small Cell Lung Cancer Patients Treated With Nivolumab and Durvalumab Monotherapy
    Meilin Jiang et al, 2020, Frontiers in Oncology CrossRef
16. Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic “dual-hit” option
    Peter Dietrich et al, 2018, Oncotarget CrossRef
17. Interventional Oncology and Immuno-Oncology: Current Challenges and Future Trends
    Alessandro Posa et al, 2023, International Journal of Molecular Sciences CrossRef
18. Minimally Invasive Therapies for Hepatocellular Carcinoma: Mechanisms of Local Control and Systemic Immunologic Response
    Andrew W. Ritchey et al, 2018, Hepatocellular Carcinoma - Advances in Diagnosis and Treatment CrossRef